Agnico Eagle Mines ( AEM ) Q4 Earnings and Revenues Surpass Estimates
Agnico (AEM) delivered earnings and revenue surprises of 7.69% and 6.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Granite Point Mortgage Trust ( GPMT ) Reports Q4 Loss, Misses Revenue Estimates
Granite Point Mortgage Trust (GPMT) delivered earnings and revenue surprises of -25.32% and 4.17%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Iamgold ( IAG ) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Iamgold (IAG) stood at $6.54, denoting a -1.06% change from the preceding trading day.
Fortuna Mining ( FSM ) Increases Yet Falls Behind Market: What Investors Need to Know
The latest trading day saw Fortuna Mining (FSM) settling at $5.38, representing a +0.37% change from its previous close.
MongoDB ( MDB ) Gains But Lags Market: What You Should Know
MongoDB (MDB) reachead $292.97 at the closing of the latest trading day, reflecting a +0.17% change compared to its last close.
RH ( RH ) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw RH (RH) settling at $380.35, representing a +1.66% change from its previous close.
Pan American Silver ( PAAS ) Stock Sinks As Market Gains: What You Should Know
Pan American Silver (PAAS) reachead $25.07 at the closing of the latest trading day, reflecting a -0.71% change compared to its last close.
Western Announces Fourth Quarter and Fiscal 2024 Results
VANCOUVER, British Columbia, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Western Forest Products Inc. ( TSX: WEF ) ( "Western" or the "Company" ) announced today improved fourth quarter and fiscal 2024 results compared to the same period last year.
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
Healthcare in vitro diagnostics company QuidelOrtho ( NASDAQ: QDEL ) attracted the right kind of attention from investors after posting its latest quarterly earnings report on Thursday. A rather encouraged market traded the company's shares up by more than 4% in response.
Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch - Moderna ( NASDAQ:MRNA )
Analysts expect Moderna to report quarterly losses of $2.68 per share and revenue of $942.84 million. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights. Moderna, Inc.
